Agilent Technologies to buy North American CDMO, Biovectra for $925 million
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire Biovectra, a leading specialized contract development and manufacturing organization (CDMO), for $925 million. Based in Canada, Biovectra produces biologics, highly potent …